Advances in the treatment of macular edema secondary to retinal vein occlusion
10.3760/cma.j.issn.2095-0160.2018.01.014
- VernacularTitle:视网膜静脉阻塞继发黄斑水肿的最新治疗进展
- Author:
Mengqi CHU
1
,
2
Author Information
1. 325027 温州医科大学附属眼视光医院
2. 浙江大学医学院附属第二医院眼科中心
- Keywords:
Retinal vein occlusion;
Macular edema;
Treatment;
Review
- From:
Chinese Journal of Experimental Ophthalmology
2018;36(1):65-69
- CountryChina
- Language:Chinese
-
Abstract:
Retinal vein occlusion (RVO) is a common blinding retinal vascular disease,and the most important complication of vision loss is macular edema (ME).The main treatment for ME secondary to RVO was laser photocoagulation therapy previously,but some researches showed that the laser therapy did not see an obvious curative effection,and might cause certain danger in some patients.In recent years,with the further understanding and research of the pathogenesis of RVO,intravitreal injection or posterior subtenon injection of triamcinolone acetonide and antivascular endothelial growth factor drugs like ranibizumab,bevacizumab,aflibercept,conbercept intravitreal injections,as well as vitreous retinal surgery gradually became the main research directions of ME secondary to RVO.The following to be a review for the advances in the treatment of macular edema secondary to RVO.
